Harvard Psychedelic-Assisted Psychotherapy: Neglected Clinical Complexities 2026
An advanced clinical training course exploring the often-overlooked psychological, ethical, spiritual, relational, cultural, and safety complexities that can arise in psychedelic-assisted psychotherapy.
Harvard Psychedelic-Assisted Psychotherapy: Neglected Clinical Complexities 2026 is a recorded educational course focused on advanced clinical, ethical, psychological, spiritual, cultural, and relational challenges in psychedelic-assisted psychotherapy.
Important Note: This course package does not include CME points or a certificate.
About This Course
As psychedelic-assisted psychotherapy continues to gain attention in mental health care, clinicians are increasingly encountering complex therapeutic situations that extend beyond traditional psychotherapy models.
This course examines practical clinical realities in psychedelic-assisted treatment, including non-ordinary states of consciousness, grief, awe, transpersonal experiences, spiritual and existential content, therapist influence, professional boundaries, adverse effects, risk management, and integration after treatment sessions.
Why Choose This Course
Key Highlights
- Advanced training focused on neglected complexities in psychedelic-assisted psychotherapy
- Covers psilocybin, MDMA-assisted psychotherapy, ketamine-assisted psychotherapy, and emerging approaches
- Explores ethical, spiritual, cultural, relational, and safety-related challenges
- Case-based approach to difficult clinical situations and non-ordinary states
- Useful for mental health clinicians, researchers, addiction specialists, and healthcare professionals
Core Learning Areas
Complete Curriculum
Foundations of Psychedelic-Assisted Psychotherapy
- Core principles and structure of psychedelic-assisted psychotherapy
- Current evidence supporting psychedelic therapies for mental health conditions
- Therapeutic preparation, support, and integration frameworks
- Multidisciplinary approaches to psychedelic-assisted care
Clinical Applications & Emerging Modalities
- Psilocybin-assisted psychotherapy
- MDMA-assisted psychotherapy
- Ketamine-assisted psychotherapy
- Other emerging psychedelic and altered-state approaches
- Case-based approaches to challenging treatment situations
Neglected Clinical Complexities
- Managing complex therapeutic encounters
- Non-ordinary states of consciousness in clinical care
- Grief, awe, and transpersonal experiences
- Spiritual, existential, religious, and cultural dimensions of treatment
- Responding to unexpected psychological material during therapy
Ethics, Risk & Patient Safety
- Recognizing potential adverse effects and treatment-related risks
- Therapist influence and power dynamics
- Professional boundaries in psychedelic-assisted therapy
- Strategies for improving patient safety and therapeutic outcomes
- Responsible clinical practice in a rapidly evolving field
Cultural Perspectives & Integration
- Western perspectives on psychedelic experiences
- Indigenous perspectives and cultural considerations
- Integration of spiritual and existential experiences into clinical care
- Culturally responsive psychedelic-assisted psychotherapy
- Post-session integration and continuity of care
Learning Objectives
By Completing This Course, You Will Be Able To:
- Understand the structure and principles of psychedelic-assisted psychotherapy
- Recognize complex clinical situations that may arise during psychedelic-assisted treatment
- Apply ethical and safety-focused strategies in psychedelic-assisted psychotherapy
- Respond to spiritual, existential, cultural, and transpersonal experiences in clinical care
- Evaluate adverse effects, boundaries, therapist influence, and patient safety risks
- Use case-based reasoning to approach difficult PAP clinical scenarios
Who Should Take This Course
This course is designed for psychiatrists, psychologists, psychotherapists, mental health counselors, behavioral health clinicians, researchers, social workers, addiction specialists, and healthcare professionals interested in psychedelic-assisted psychotherapy and its clinical complexities.
Delivery & Access
This course package is provided for recorded learning access only. No CME points or certificate are associated with this course.
Reviews
A thoughtful and clinically important course. The focus on boundaries, safety, and neglected complexities makes it especially valuable.
Very useful for understanding the deeper clinical and ethical dimensions of psychedelic-assisted psychotherapy beyond the usual introductory content.
The case-based approach and discussion of risk, culture, and integration were practical and highly relevant for mental health professionals.
FAQ
Who is this course best suited for?
It is ideal for psychiatrists, psychologists, psychotherapists, mental health counselors, behavioral health clinicians, researchers, social workers, addiction specialists, and healthcare professionals interested in psychedelic-assisted psychotherapy.
What topics are covered?
The course covers psychedelic-assisted psychotherapy principles, psilocybin, MDMA-assisted psychotherapy, ketamine-assisted psychotherapy, complex therapeutic encounters, altered states, spiritual and cultural dimensions, adverse effects, ethics, boundaries, safety, and integration.
Does this course include CME or a certificate?
No. This course package does not include CME points or a certificate.
Who can I contact for support?
You can contact us at [email protected].
Reviews
There are no reviews yet.